|
Q4 2023
Filed on Nov 04, 2024
|
0
|
$8.77 - $15.96
$0 - $0
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
1,790
|
$13.3 - $15.17
$23.8K - $27.2K
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
116
|
$222.45 - $263.73
$25.8K - $30.6K
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
431
|
$7.85 - $8.94
$3.38K - $3.85K
|
|
Gsk PLC Adr Fsponsored Adr 1 Adr Reps 2 Ord Shs
|
Q3 2023
Filed on Nov 04, 2024
|
345
|
N/A
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
50,000
|
N/A
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
100,000
|
N/A
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
110
|
$26.65 - $36.25
$2.93K - $3.99K
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
37
|
$132.53 - $173.22
$4.9K - $6.41K
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
278
|
N/A
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
50,000
|
N/A
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
50,000
|
N/A
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
557
|
$57.36 - $74.31
$31.9K - $41.4K
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
39
|
$75.56 - $137.34
$2.95K - $5.36K
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
807
|
N/A
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
111
|
$19.1 - $28.49
$2.12K - $3.16K
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
50,000
|
N/A
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
60
|
$122.0 - $145.31
$7.32K - $8.72K
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
50,000
|
N/A
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
50,000
|
N/A
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
1,000
|
N/A
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
50,000
|
N/A
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
206
|
$29.45 - $45.67
$6.07K - $9.41K
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
10,000
|
N/A
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
40
|
$39.29 - $68.17
$1.57K - $2.73K
|
|
Vanguard High Yield Corporate Inv
|
Q4 2023
Filed on Nov 04, 2024
|
14,597
|
N/A
|
|
Us Treasury Bill23 U S T Bill Due 07/13/23
|
Q3 2023
Filed on Nov 04, 2024
|
50,000
|
N/A
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
219
|
$49.93 - $56.46
$10.9K - $12.4K
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
100
|
$6.62 - $10.32
$662 - $1.03K
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
259
|
$49.12 - $62.1
$12.7K - $16.1K
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
303
|
$90.32 - $100.49
$27.4K - $30.4K
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
50,000
|
N/A
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
340
|
$52.63 - $62.01
$17.9K - $21.1K
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
734
|
$16.47 - $18.11
$12.1K - $13.3K
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
98
|
$120.85 - $137.87
$11.8K - $13.5K
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
50,000
|
N/A
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
150,000
|
N/A
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
53,000
|
N/A
|
|
T. Rowe Price International Stock
|
Q3 2023
Filed on Nov 04, 2024
|
135
|
N/A
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
428
|
$0.0 - $94.47
$0 - $40.4K
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
53,000
|
N/A
|
|
Alternative Credit Income Fund Cl W Shs
|
Q4 2023
Filed on Nov 04, 2024
|
917
|
N/A
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
246
|
$57.89 - $64.73
$14.2K - $15.9K
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
50,000
|
N/A
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
50,000
|
N/A
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
50,000
|
N/A
|
|
|
Q3 2023
Filed on Nov 04, 2024
|
50,000
|
N/A
|
|
|
Q4 2023
Filed on Nov 04, 2024
|
50,000
|
N/A
|
|
|
Q4 2022
Filed on Oct 07, 2024
|
400
|
$21.6 - $142.55
$8.64K - $57K
|
|
|
Q4 2022
Filed on Oct 07, 2024
|
100
|
$0.0 - $0.36
$0 - $36
|
|